Evaluation of pharmaceutical care services in the Middle East Countries: a review of studies of 2013-2020
- PMID: 37461105
- PMCID: PMC10351150
- DOI: 10.1186/s12889-023-16199-1
Evaluation of pharmaceutical care services in the Middle East Countries: a review of studies of 2013-2020
Abstract
Introduction: Pharmaceutical care services (PCs) have evolved significantly over the last few decades, with a greater focus on patient's safety and proven effectiveness in a wide range of contexts. Many of the evidence supporting this technique comes from the United States, the evaluation and adoption of (PCs) which differ greatly across the globe.
Objective: The goal of this study was to identify and assess the efficacy of pharmaceutical care services in various pharmaceutical aspects throughout seventeen Middle Eastern nations.
Method: The Arkesy and O'Malley technique was used to conduct a scoping review. It was conducted using PubMed/Medline, Scopus, Cochrane Library, Springer Link, Clinical Trials, and Web of Science etc. The Van Tulder Scale was utilized in randomized trials research, whereas the dawn and black checklists were used in non-randomized trials research. A descriptive and numerical analysis of selected research was done. The scope of eligible PCs, pharmaceutical implementers, study outcomes, and quality were all identified by a thematic review of research.
Results: There were about 431,753 citations found in this study, and 129 publications were found to be eligible for inclusion after analysing more than 271 full-text papers. The study design was varied, with 43 (33.3%) RCTs and 86 (66.7%) n-RCTs. Thirty-three (25.6%) of the studies were published in 2020. Jordan, Saudi Arabia, and Turkey were home to the majority of the studies (25.6%, 16.3%, and 11.6%) respectively. Thirty-seven studies (19.7%) were concerned with resolving drug related problems (DRPs), whereas 27 (14.4%) were concerned with increasing quality of life (QOL) and 23 (12.2%) with improving drug adherence. Additionally, the research revealed that the average ratings of the activities provided to patients improved every year.
Conclusion: Studies in the Middle East continue to provide evidence supporting the positive impact of pharmaceutical care services on both hard and soft outcomes measured in most studies. Yet there was rare focus on the value of the implemented services. Thus, rigorous evaluation of the economic impact of implemented pharmaceutical care services in the Middle East and assessment of their sustainability is must.
Keywords: Assessment; Clinical pharmacy services; Middle East; Pharmaceutical Care Services; Pharmacy practice.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interest.
Figures



Similar articles
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001. JBI Libr Syst Rev. 2009. PMID: 27820426
-
How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?Int J Evid Based Healthc. 2008 Mar;6(1):78-110. doi: 10.1111/j.1744-1609.2007.00098.x. Int J Evid Based Healthc. 2008. PMID: 21631815
-
Medical abortion offered in pharmacy versus clinic-based settings.Cochrane Database Syst Rev. 2021 Jun 11;6(6):CD013566. doi: 10.1002/14651858.CD013566.pub2. Cochrane Database Syst Rev. 2021. PMID: 34114643 Free PMC article.
-
The impact of hospital accreditation in selected Middle East countries: a scoping review.J Health Organ Manag. 2021 Aug 17;ahead-of-print(ahead-of-print). doi: 10.1108/JHOM-04-2021-0159. J Health Organ Manag. 2021. PMID: 34390550
Cited by
-
Impact of pharmacist-supported transition of care services in the Middle East and North Africa: a systematic review and meta-analysis.J Pharm Policy Pract. 2024 Mar 11;17(1):2323099. doi: 10.1080/20523211.2024.2323099. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 38476501 Free PMC article. Review.
-
A Systematic Review of Controlled Trials: Can Patient Adherence to Antibiotics Be Improved Through Pharmaceutical Communication-Based Interventions?Pharmacy (Basel). 2024 Nov 26;12(6):178. doi: 10.3390/pharmacy12060178. Pharmacy (Basel). 2024. PMID: 39728843 Free PMC article. Review.
-
Impact of Pharmacist Interventions on Health Outcomes of Patients with Type 2 Diabetes Mellitus in the Middle East: A Systematic Review.Integr Pharm Res Pract. 2025 May 8;14:85-98. doi: 10.2147/IPRP.S515197. eCollection 2025. Integr Pharm Res Pract. 2025. PMID: 40357005 Free PMC article. Review.
-
The evolving role of pharmacists in depression care: a scoping review.Int J Clin Pharm. 2024 Oct;46(5):1044-1066. doi: 10.1007/s11096-024-01759-1. Epub 2024 Jul 15. Int J Clin Pharm. 2024. PMID: 39007991 Free PMC article.
-
Pharmacy Customers' Attitudes Towards Expanded Pharmacy Services in Croatia.Pharmacy (Basel). 2024 Dec 31;13(1):2. doi: 10.3390/pharmacy13010002. Pharmacy (Basel). 2024. PMID: 39846625 Free PMC article.
References
-
- Cooke LH. Re-implementation synthesis. ” Dig Pap - IEEE Comput Soc Int Conf. 1989;462–8. 10.1109/cmpcon.1989.301976.
-
- Michie S. Implementation science: understanding behaviour change and maintenance. BMC Health Serv Res. 2014;14:6963. doi: 10.1186/1472-6963-14-s2-o9. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources